Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5103 Target Snapshot

Polyamine deacetylase HDAC10 · SINGLE PROTEIN · Homo sapiens

645Compounds
275Assays
10Approved Drugs
839.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q969S8. Use UniProt Q969S8 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q969S8 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Polyamine deacetylase HDAC10 as ChEMBL target CHEMBL5103, mapped to UniProt Q969S8. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Polyamine deacetylase HDAC10
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL5103
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q969S8
Polyamine deacetylase HDAC10
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Polyamine deacetylase HDAC10 is the right protein anchor across sources, using UniProt Q969S8 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPolyamine deacetylase HDAC10
UniProt AccessionQ969S8
Component TypeProtein
Sequence Length669 aa

Polyamine deacetylase HDAC10

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Polyamine deacetylase HDAC10, mapped to UniProt Q969S8. Sequence length is 669 aa.

Mapped IDQ969S8
Review namePolyamine deacetylase HDAC10
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

10
Approved
7
Phase III
6
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC50770.0
KI67.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2105763 10.3 Ki 0.05 Clinical
CHEMBL3329621 9.7 IC50 0.2 Preclinical
CHEMBL2105763 9.34 IC50 0.46 Clinical
CHEMBL1796689 9.3 IC50 0.5 Preclinical
CHEMBL3329622 9.3 IC50 0.5 Preclinical
CHEMBL3593247 9.3 IC50 0.5 Preclinical
CHEMBL4532398 9.24 IC50 0.58 Preclinical
CHEMBL3827517 9.07 IC50 0.86 Preclinical
CHEMBL343448 9.05 IC50 0.9 Approved
CHEMBL5618885 9.05 IC50 0.9 Preclinical
Distribution

pChEMBL Value Distribution

83
5.0
58
5.5
75
6.0
92
6.5
97
7.0
81
7.5
50
8.0
28
8.5
14
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

GIVINOSTAT
CHEMBL1213492
Approved 2024
PANOBINOSTAT
CHEMBL483254
Approved 2015
BELINOSTAT
CHEMBL408513
Approved 2014
ROMIDEPSIN
CHEMBL343448
Approved 2009
BENDAMUSTINE
CHEMBL487253
Approved 2008
VORINOSTAT
CHEMBL98
Approved 2006
Assay Landscape

Assay Landscape

275
Total Assays
473
Tested Compounds
3
Assay Types
Binding — 270 assays, 473 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 222 371 6.6
cell-based format 37 94 6.8
assay format 10 8 5.9
organism-based format 1 0
ADME — 4 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 3 4 5.3
cell-based format 1 2 7.3
Toxicity — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine